We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Careside Validates Manufacturing System

By HospiMedica staff writers
Posted on 31 Jan 2001
Following an independent review of the quality management system for the Careside Analyzer, Careside, Inc. More...
(Culver City, CA, USA) has announced that the system meets ISO 9001 standards and is compliant with U.S. Food and Drug Administration (FDA) requirements. The review was made by Arthur D. Little (ADL), a global management and technology consulting firm.

ADL was retained to review design details of the various technology components of the Analyzer as well as the manufacturing process used by the contract manufacturer. This review resulted in the implementation of design improvements in the manufacturing process of the Analyzer. The review did not include the manufacturing process or product design of the system's test cartridges.

Careside's Analyzer provides an efficient means of measuring blood chemistry, electrochemistry, and coagulation function at the patient's point of care by producing test results within 15 minutes. "While we experienced initial problems common in the manufacturing of complex medical devices, the current manufacturing process is meeting our expectation and consistently producing high-quality and reliable instruments,” said Vickery Stoughton, chairman and CEO of Careside.



Related Links:
Careside Inc

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Urinalysis Solution
UN-9000
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.